SCWorx Announces Completion of Equity Financing with Institutional Investors
20 Novembre 2024 - 10:43PM
SCWorx Corp (the “Company”), on November 19
th,
2024 completed an equity financing with institutional investors
(the “Institutional Investors” or “Investors”). In connection with
the funding, the Company sold an aggregate of 232,558 shares of
common stock and warrants to purchase the same number of shares of
common stock, for aggregate gross proceeds of $200,000.
The Company will be registering for resale the
shares of common stock and warrant shares with U.S. Securities and
Exchange Commission (the “SEC”).
SCWorx expects to use net proceeds from the
financing for working capital and general corporate purposes to
support its future growth.
This news release shall not constitute an offer
to sell or the solicitation of an offer to buy, nor shall there be
any sale of any of the securities referred to in this news release
in any state in which such offer, solicitation or sale would be
unlawful prior to the registration or qualification under the
securities laws of any such state. Any offering of SCWorx’s common
stock under the resale registration statement referred to in this
news release will be made only by means of a prospectus.
About
SCWorx
SCWorx has created an advanced attributed
virtualized item data warehouse utilizing machine learning and
artificial intelligence to offer a suite of
software-as-a-service-based solutions for healthcare providers. The
value proposition for customers revolves around the full
integration of all solution modules with the company’s data
platform for cost savings, operational efficiency and accurate
benchmarking and reporting. The solution modules include Virtual
Item Master, data cleanse and normalization, contract management
and request for pricing (RFP) module, automated rebate management
module, data interoperability (EMR, MMIS, finance) module,
Automated Item Add Portal, Virtual General Ledger, and the data
analytics module. SCWorx creates a single source for information
for the healthcare provider’s data governance and analytics
requirements.
Forward-Looking
Statements
This press release contains “forward-looking
statements” that involve substantial risks and uncertainties for
purposes of the safe harbor provided by the Private Securities
Litigation Reform Act of 1995. All statements, other than
statements of historical facts, included in this press release
regarding strategy, future operations, future contract renewals and
terminations, future financial position, prospects, plans and
objectives of management are forward-looking statements. You can
identify many (but not all) such forward-looking statements by
looking for words such as “assumes,” “approximates,” “believes,”
“expects,” “anticipates,” “estimates,” “projects,” “seeks,”
“intends,” “plans,” “could,” “would,” “may” or other similar
expressions. You should not place undue reliance on these
forward-looking statements. Such statements are based on
management’s current expectations and involve risks and
uncertainties. Actual results and performance could differ
materially from those projected in the forward-looking statements
as a result of many factors, including, without limitation,
economic disruptions affecting our customers, unexpected contract
terminations, securing future contracts and orders, future product
sourcing, supply disruptions, containing costs, the ability to
project future cash utilization and reserves needed for contingent
future liabilities and business operations, the availability of
sufficient resources of the company to meet its business objectives
and operational requirements and other important factors that are
detailed in filings with the Securities and Exchange Commission
made from time to time by SCWorx, including its Annual Report on
Form 10-K for the year ended December 31, 2023, Quarterly Reports
on Form 10-Q, and Current Reports on Form 8-K. Matters described in
forward-looking statements may also be affected by other known and
unknown risks, trends, uncertainties and factors, many of which are
beyond the company’s ability to control or predict. SCWorx
undertakes no obligation to release publicly any revisions to any
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated
events.
Contacts:
ir@scworx.com
###Source: SCWorx Corp.
Grafico Azioni SCWorx (NASDAQ:WORX)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni SCWorx (NASDAQ:WORX)
Storico
Da Dic 2023 a Dic 2024